Companies: 10,795·Total market cap: $144.5T
Cognetivity Neurosciences Ltd.

Cognetivity Neurosciences Ltd.

CGNSFOTCHealthcare● Active
$0.00
$-0.00(-0.00%)
Market Cap$8959
P/E Ratio
52W High$0.0019
52W Low$0.000099999997
Overview

Cognetivity Neurosciences Ltd. (CGNSF) Revenue

Annual & quarterly revenue history · segment & region breakdown

CGNSF · revenue · updated Jun 10, 2026

Core revenue metrics

Cognetivity Neurosciences Ltd. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
0.09×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$0K
2500 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Cognetivity Neurosciences Ltd. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
CGNSF revenue by year · CGNSF revenue history · CGNSF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Cognetivity Neurosciences Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Cognetivity Neurosciences Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Cognetivity Neurosciences Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

CGNSF revenue · 4 questions

CGNSF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

CGNSF revenueCGNSF annual revenuewhat is CGNSF revenueCGNSF TTM revenue

Source: FMP · Cognetivity Neurosciences Ltd. SEC filings · GAAP · Cognetivity Neurosciences Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026